Efficacy of traditional Chinese medicines in the treatment of solar lentigo based on network pharmacology and experimental validation
Journal of Cosmetic Dermatology · 2024
DOI: 10.1111/jocd.16507 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Dongmei Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: The School of Biomedical and Pharmaceutical Engineering, Guangdong University of Technology, Guangzhou, China. Hauptthemen laut MEDLINE: Lentigo, Network Pharmacology, Medicine, Chinese Traditional, Drugs, Chinese Herbal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Aims Solar lentigo is a prevalent skin condition that affects a significant number of individuals. Fortunately, certain traditional Chinese medicines and monomers (TCMM) have proven effective in addressing these concerns. In this study, we evaluated the efficacy and underlying mechanism of TCMM, a combination of TCM and monomers in repairing solar lentigo.
Methods
We detected and identified the main compounds of TCM using liquid chromatography‐mass spectrometry (LC–MS) and through the approach of network pharmacology, we screened drug and disease targets, visualized networks with Cytoscape software, analyzed targets via Gene ontology and KEGG, clinically validated predictions. In a mouse model, UVB‐induced pigmentation was assessed, and the effects of TCMM were evaluated. A clinical trial on 30 patients validated the depigmenting agent.
Results
Active ingredients such as MSH, Butylated hydroxytoluen, Valerophenone, and Geranylacetone aid pigmentation treatment. One hundred and forty‐three crore targets impact PI3K‐Akt, MAPK signaling pathway, ect. pathways. TCMM reduced UVB‐induced pigmentation, water loss, epidermal thickness, and melanin. It inhibited TYR, MITF, AKT1, VEGFA, PTGS2, TNF‐α, IL‐6, IL‐1β. Clinical and microscopic analysis showed significant pigmentation reduction.
Conclusions
The treatment of solar lentigo can benefit from the TCMM. By targeting multiple factors and pathways, this approach offers a comprehensive and effective treatment strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The School of Biomedical and Pharmaceutical Engineering, Guangdong University of Technology, Guangzhou, China.
- Infinitus Company Ltd., R&D Center, Guangzhou, China.
- Foshan Conney Allan Biotechnology Co. Ltd, Foshan, China.
- State Key Laboratory Basis of Xinjiang indigenous medicinal plants resource utilization, CAS Key Laboratory of Chemistry of Plant Resources in Arid Regions, Xinjiang Technical Institute of Physics and Chemistry, Chinese…
- University of Chinese Academy of Sciences, Beijing, China.
ORCID-Profile: Dongmei Wu
Zitieren
APA
Wu, D., Lv, P., Han, P., Xie, L., Li, Y., Ma, C., Tai, M., Peng, Y., & Lin, L. (2024). Efficacy of traditional Chinese medicines in the treatment of solar lentigo based on network pharmacology and experimental validation. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16507
Vancouver
Wu D, Lv P, Han P, Xie L, Li Y, Ma C, et al. Efficacy of traditional Chinese medicines in the treatment of solar lentigo based on network pharmacology and experimental validation. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16507
BibTeX
@article{Wu2024,
author = {Wu, Dongmei and Lv, Pingping and Han, Ping and Xie, Lingna and Li, Yi and Ma, Congwei and Tai, Meiling and Peng, Yi and Lin, Li},
title = {Efficacy of traditional Chinese medicines in the treatment of solar lentigo based on network pharmacology and experimental validation},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
doi = {10.1111/jocd.16507}
}
EUVIMED